NEURESA

Serial Number 78073706
606

Registration Progress

Application Filed
Jul 12, 2001
Under Examination
Feb 12, 2002
Approved for Publication
Oct 31, 2001
Published for Opposition
Nov 20, 2001
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NEURESA
Previous Owner: Avanir Pharmaceuticals, Inc.
Classes: 005

Trademark Image

NEURESA

Basic Information

Serial Number
78073706
Filing Date
July 12, 2001
Published for Opposition
November 20, 2001
Abandonment Date
August 13, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 13, 2003
Classes
005

Rights Holder

Avanir Pharmaceuticals, Inc.

03
Address
11388 Sorrento Valley Road
San Diego, CA 92121

Ownership History

Avanir Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Avanir Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
STEPHEN C. CLIFFORD

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Oct 8, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 14, 2003 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 24, 2003 FAXX I FAX RECEIVED Loading...
Apr 24, 2003 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 22, 2003 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 22, 2003 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 9, 2002 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 22, 2003 MAIL I PAPER RECEIVED Loading...
Dec 16, 2002 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 12, 2002 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 20, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 31, 2001 NPUB O NOTICE OF PUBLICATION Loading...
Aug 26, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 23, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and rehabilitation of neurological disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005